When numerous trials demonstrate that THC and CBD make improvements to MS indicators, the impact is small. There may be also no convincing evidence that cannabinoids can sluggish or reverse the disease’s progression. An additional 2022 trial involving 186 Grownups with ache, sleeplessness, stress and anxiety or depressive signs https://henryy964vtd0.wikistatement.com/user